J3376 — Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mg
J3376 is a HCPCS Level II code for injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
Physician fee schedule statusE
Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).
Global period: XXX
Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.
The CMS record for J3376
- Long descriptor
- Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mg
- Short descriptor
- Inj vancomycin (hikma) 10mg
- Added
- January 1, 2026
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J3376
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J3376 is not quite right, the correct code is very often within a few positions of it.
- J3364Injection, urokinase, 5000 iu vialterminated
- J3365Injection, iv, urokinase, 250,000 i.u. vialterminated
- J3370Injection, vancomycin hcl, 500 mgterminated
- J3371Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mgterminated
- J3372Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mgterminated
- J3373Injection, vancomycin hydrochloride, 10 mg
- J3374Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mg
- J3375Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mg
- J3379Injection, valproate sodium, 5 mg
- J3380Injection, vedolizumab, intravenous, 1 mg
- J3385Injection, velaglucerase alfa, 100 units
- J3386Injection, etuvetidigene autotemcel, per treatment
- J3387Injection, elivaldogene autotemcel, per treatment
- J3389Topical administration, prademagene zamikeracel, per treatment
- J3391Injection, atidarsagene autotemcel, per treatment
- J3392Injection, exagamglogene autotemcel, per treatment
Questions about J3376
What is HCPCS code J3376?
J3376 is a HCPCS Level II code for injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J3376?
The CMS HCPCS file marks J3376 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
How is J3376 paid under the physician fee schedule?
J3376 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).